BNGO News and Press, Bionano Genomics Inc. From 10/26/22

Bionano Genomics' ( NASDAQ: BNGO ) Long String VANTAGE, asystem for automated, high throughput isolation of ultra high molecular weight (UHMW) DNA for optical genome mapping (OGM), is now available . Bionano ( BNGO ) CEO Erik Holmlin said that UHMW DNA analysis "ca...

SAN DIEGO and RENO, Nev., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Hamilton and Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that the Long String VANTAGE, a system for automated, high throughput isolation of ultra high molecular weight (UHMW) DNA for use in optical genome mapping (OG...

Shares of genome analysis company Bionano Genomics (NASDAQ: BNGO) rose 16.42% on Tuesday. The stock closed on Monday at $2.01, then opened on Tuesday at $2.10. It rose to a high of $2.42 around noon before closing at $2.34. The stock has a 52-week low of $1.16 and a 52-week high of ...

SAN DIEGO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that the company will host a “Meet the User” event today, October 24, 2022, at its new CLIA-certified Bionano Laboratories facility in advance of the American Society of Human Genetics...

Dr. Alka Chaubey, chief medical officer at Bionano, and Dr. Nikhil Sahajpal, fellow at Greenwood Genetic Center, will host a sponsored vendor presentation on a large clinical study utilizing optical genome mapping (OGM) for analysis of postnatal genetic disorders and the complement...

Summary Bionano Genomics makes a machine to perform optical genome mapping, a useful technique for understanding chromosomal damage. We contend however that there is little utility for this device outside of the research lab and that the market is too small to support the company'...

SAN DIEGO, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a peer-reviewed study evaluating optical genome mapping (OGM) as a method for investigating abnormal noninvasive prenatal testing (NIPT) results because of its ability to ac...

SAN DIEGO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation at the Spanish Society of Hematology (SEHH) 2022 Conference, with six scientific presentations from independent researchers covering a wide variety of the cancer genomic...

U.S. stocks fell on Wednesday, giving back some of its sharp gains from the last two sessions as Treasury yield rose. The Dow Jones Industrials descended 305.23 points, or 1%, from Tuesday's lofty perches to 30,011.09. The S&P 500 docked 52.66 points, or 1.4%, to 3,738.27. T...

BNGO stock closed Tuesday trading at $2.0400 at close: 04:00 PM EDT On October 4, Bionano Genomics ( NASDAQ:BNGO ) reported that a study found that whole genome sequencing (WGS) only identified 63% of structural alterations discovered by optical genome mapping ...